tirzepatide august 24 2025 Mounjaro health benefits found to reverse one year after stopping drug Just started 2.5mg tirzepatide :

Findings of the prespecified analysis of the trial, published in The Lancet, suggest that semaglutide and possibly other glucagon-like peptide-1 receptor agonists (GLP-1Ras) should be reconceptualised as disease-modifying treatments rather than solely medications for glycaemic control or weight loss, the studys authors have suggested

Some individuals may experience relatively modest increases, whilst others see substantial rises in HbA1c over subsequent months

That dual action explains its stronger metabolic and anti-inflammatory effects. When I say GLP-1 medications in this article, I mean this whole family

Semaglutide treatment offers a clinically proven method to help manage chronic weight issues